Hyaluronic Acid Dermal Filler Market (By Product: Single-phase, Duplex product; By Application: Wrinkle removal, Lip augmentation, Rhinoplasty, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The global hyaluronic acid dermal filler market is anticipated to reach USD 6.06 billion by 2026. The market is expected to register a growth of 8.35% CAGR during the forecast period. This global growth can be attributable to growing awareness and importance of quality of life and overall health among the population worldwide. Additionally, scientific developments and technical innovations in the industry are likely to encourage the market growth further. In 2016, as per the International Society of Plastic Surgery (ISAPS), hyaluronic acid based dermal filler measures were the second-most preferred injectable procedures across the globe.

Market Dynamics

Rising disposable income and strong influence of social media are the key factors encouraging the global hyaluronic acid dermal filler market growth. Moreover, technological advancements resulting in reduced procedure and recovery time are likely to augment the demand over the forecast period. This global growth can be attributable to growing awareness and importance of quality of life and overall health among the population worldwide. Additionally, scientific developments and technical innovations in the industry are likely to encourage the market growth further.

Market Insights

In 2016, as per the fact provided by the International Society of Plastic Surgery, near about 8,500,000 non-surgical procedures were performed worldwide. This increase in health awareness and consciousness concerning the change in beauty standards among the population have led to a rise in demand for cosmetics and aesthetics procedures. This factor is also expected to have a positive impact on the global hyaluronic acid dermal filler market development.

The hyaluronic acid dermal fillers are frequently used for aesthetic procedures, such as reducing eye wrinkles, dark circles, scars, and improving nasolabial folds. Hyaluronic acid injections are characterised by ease of usage, relatively less expensive and comparatively highly effective. These coupled factors are expected to drive the growth of the global hyaluronic acid fillers market during the forecast period. Growing popularity and awareness of aesthetic measures for cosmetic makeover along with the easy availability of hyaluronic acid-based synthetic products which are FDA-approved, such as Juvederm, Perlane, Hylaform Plus, and Restylane, are also expected to drive the market growth during the forecast period.

Market Segmentation

Market By Product

  • Single-phase
  • Duplex product

Market By Application

  • Wrinkle removal,
  • Lip augmentation
  • Rhinoplasty
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

In 2017, among the regions, the North America hyaluronic acid dermal filler market held greater market share on account of higher number of minimally invasive cosmetic surgeries performed in the region. Asia Pacific hyaluronic acid dermal filler market is expected to witness greater CAGR during the forecast period, due to growing awareness about applications of minimally invasive techniques in emerging economies, such as China, and increasing disposable income levels.

Market Participants

The key players catering to the global hyaluronic acid dermal filler market are Genzyme Corporation, ALLERGAN PLC; Galderma S.A.; Medicis Aesthetics Holdings, Inc.; Anika Therapeutics, Inc. and Merz Pharma GmbH & Co. KGaA. The global players are continuously investing in R&D activities and innovating to have updated product portfolio to attract more and more business opportunity from the emerging nation such as that in Asia Pacific countries. Further changing customers’ preferences are encouraging global players to develop user friendly products with best experience for the users to cater best to the market. Also, Increasing R&D investments coupled with technological advancements to commercialise highly efficient products are anticipated to offer lucrative opportunities for industry participants.


Related Reports

Tumor Necrosis Factor (TNF) Inhibitor Drugs Market (By Product: Simponi/Simponi Aria, Remicade, Enbrel, Cimzia, Humira, Biosimilars; By Application: Psoriatic Arthritis, Crohn’s Disease, Rheumatoid Arthritis, Psoriasis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Ulcerative Colitis, Ankylosing Spondylitis, Others; By Sales Channel: Online Pharmacies, Specialty Pharmacies, Hospital Pharmacies) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global TNF Inhibitor Drugs market is forecasted to grow at striking CAGR around 0.6% over the forecast time frame and reach around US$ 41 billion by 2026. TNF inhibitors or factor inhibitors of tumor necrosis are biological medicines extracted from human or animal tissue, most frequently used to preve

Scleroderma Therapeutics Market (By Drug Class: Immunosuppressors, Endothelin Receptor Antagonists, Phosphodiesterase 5 Inhibitors - PHA, Calcium Channel Blockers, Analgesic, Prostacyclin Analogues, Others; By Indication: Systemic, Localized) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global scleroderma therapeutics market is forecasted to grow at striking CAGR around 6.4% over the forecast time frame and reach around US$ 3.8 billion by 2026. It is an autoimmune rheumatic condition which causes the skin and connective tissues to get chronically hardened and tightened. However, it i

Orthopedic Biomaterials Market (By Material Type: Calcium Phosphate Cements, Ceramics & Bioactive Glasses, Polymers, Composites, Metal; By Application: Joint Replacement/Reconstruction, Orthopedic Implants, Viscosupplementation, Bio-resorbable Tissue Fixation, Orthobiologics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global orthopedic biomaterials market size is expected to reach around US$ 26 billion by 2026 growing at noteworthy CAGR around 10.0 % throughout the forecast period 2019 to 2026. Organic or synthetic biomaterials used for inner fracture fixation are biological materials of biological structure. For m

Oral Irrigator Market (By Type: Countertop, Cordless; By Application: Home, Dentistry) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global oral irrigator market value is expected to reach around US$ 1 billion by 2026 growing at CAGR around 3.6% over the forecast time frame 2019 to 2026. The device used to remove plaque and debris from between teeth is dental water or oral water irrigation. This method is carried out with a pulse w

Irritable Bowel Syndrome Treatment Market (By Type: IBS-D [Viberzi, Xifaxan, Others], IBS-C [Amitiza, Linzess/Constella, Others]; By Product: Viberzi, Linzess/Constella, Xifaxan, Amitiza, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Irritable Bowel Syndrome Treatment market is expected to grow at noteworthy CAGR around 9.8 % throughout the forecast period and reach around US$ 3.4 billion by 2026. IBS is a gastrointestinal functional disorder of the intestine that is characterized by contractions of the colon muscle. The bi

Cart Summary